The head of Novo Nordisk's Bio Innovation Hub on collaborating to modify cardiometabolic diseases

blonca9
Sep 26, 2023
1 min read

Uli Stilz talks about the collaborations Novo is making with institutions and companies to work on science that might slow or reverse the progression of cardiometabolic diseases.

Recent Posts

See All

As federal funding for cancer research has been jeopardized at NIH and academia, Parker Institute for Cancer Immunotherapy is one private institution ready to step up and broaden its impact

Mount Sinai has embraced AI as a drug discovery tool by launching this month its new AI Small Molecule Drug Discovery Center - Professor Avner Schlessinger tells us why

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Soumit Roy and Justin Walsh share their take on biotech and comment on companies they cover

The head of Novo Nordisk's Bio Innovation Hub on collaborating to modify cardiometabolic diseases

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight